🔎 Trials Near Me

Akèy › Twoub depresif majè › Florid › Miami

Etid klinik pou Twoub depresif majè nan Miami, FL

18 etid pou Twoub depresif majè ap chèche patisipan nan sit nan ak bò kote Miami (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • Miami Jewish health, Miami
  • Quantix Research - Miami - Southwest 72nd Street, Miami
  • Diverse Clinical Research, Miami
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT07775300

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Ap rekriteFaz 3
  • Pharmax Research Clinic Inc, Miami
  • Nuovida Research Center, Miami
Laj 18 a 74 · Tout sèks · Mizajou Oct 1, 2026 · NCT07573176

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Ap rekriteFaz 3
  • Pharmax Research Clinic Inc, Miami
  • Miami Dade Medical Research Institute, Miami
  • Nuovida Research Center, Miami
Laj 18 a 74 · Tout sèks · Mizajou Sep 25, 2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 2
  • Central Miami Medical Institute Llc., Miami
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07621237

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Ap rekriteFaz 3
  • Premier Clinical Research Institute, Miami
  • Miami Jewish Health System, Miami
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT05850689

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Ap rekriteFaz 3
  • Vanda Investigational Site, Miami
Laj 18 a 65 · Tout sèks · Mizajou Sep 24, 2026 · NCT06830044

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Ap rekriteFaz 2
  • Draig Clinical Site, Miami
Laj 18 a 75 · Tout sèks · Mizajou Aug 26, 2026 · NCT07300969

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Miami
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT06963021

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Ap rekriteFaz 3
  • PharmaSouth Research, Miami
Laj 18 a 74 · Tout sèks · Mizajou Aug 3, 2026 · NCT06775379

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Ap rekriteFaz 2
  • Premier Clinical Research Institute, Inc., Miami
  • Miami Dade Medical Research Institute, Miami
Laj 18 a 64 · Tout sèks · Mizajou Aug 3, 2026 · NCT06547489

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Ap rekriteFaz 2
  • Premier Clinical Research Institute Inc, Miami
Laj 18 a 64 · Tout sèks · Mizajou Jul 27, 2026 · NCT07115329

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Miami
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Ap rekriteFaz 3
  • Clinical Research Site, Miami
  • Clinical Research Site, Miami
Laj 18 a 65 · Tout sèks · Mizajou Jul 24, 2026 · NCT07484217

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Ap rekriteFaz 2
  • GMI Florida - Central Miami Medical Institute /ID# 278218, Miami
Laj 18 a 65 · Tout sèks · Mizajou Jun 15, 2026 · NCT07276997

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Ap rekriteFaz 2
  • Bioresearch Partner, Miami
Laj 18 a 65 · Tout sèks · Mizajou May 11, 2026 · NCT06524830

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

Ap rekriteFaz 2
  • Autobahn Site #111, Miami
Laj 18 a 65 · Tout sèks · Mizajou Jan 20, 2026 · NCT06633016

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Ap rekriteFaz 4
  • Clinical Research Site, Miami
Laj 18 a 65 · Tout sèks · Mizajou Jan 23, 2025 · NCT06223880

Etid Twoub depresif majè nan lòt vil

Lòt etid nan Miami

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.